Migrastatin Analogues Inhibit Canine Mammary Cancer Cell Migration and Invasion

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Majchrzak, Kinga ^a   Lo Re, Daniele ^b   Gajewska, Małgorzata ^a   Bulkowska, Małgorzata ^a   Homa, Agata ^a   Pawłowski, Karol ^a   Motyl, Tomasz ^a   Murphy, Paul V ^b   Król, Magdalena ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; F ACTIN; FASCIN; FASCIN 1; MIGRASTATIN 1; MIGRASTATIN 2; MIGRASTATIN 3; MIGRASTATIN 4; MIGRASTATIN 5; MIGRASTATIN 6; MIGRASTATIN 7; MIGRASTATIN 8; MIGRASTATIN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; WNT PROTEIN;

ADENOCARCINOMA; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR INVASION;

ACTINS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; COLLAGEN; CYTOSKELETON; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; LAMININ; MACROLIDES; MAMMARY NEOPLASMS, ANIMAL; MICROFILAMENT PROTEINS; MICROSCOPY, CONFOCAL; MODELS, CHEMICAL; MOLECULAR STRUCTURE; NEOPLASM INVASIVENESS; PIPERIDONES; PROTEOGLYCANS;

EID: 84885161475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076789     Document Type: Article

References (35)

1. Chaffer CL, Weinberg RA, (2011) A perspective on cancer cell metastasis. Science 331: 1559-1564. doi:10.1126/science.1203543. PubMed: 21436443.
2. Pavelic SK, Sedic M, Bosnjak H, Spaventi S, Pavelic K, (2011) Metastasis: new perspectives on an old problem. Mol Cancer 10: 22. doi:10.1186/1476-4598-10-22. PubMed: 21342498.
3. Nakae K, Yoshimoto Y, Sawa T, Homma Y, Hamada M, et al. (2000) Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F. J Antibiot 53: 1130-1136. doi:10.7164/antibiotics.53.1130. PubMed: 11132958.
4. Nakae K, Yoshimoto Y, Ueda M, Sawa T, Takahashi Y, et al. (2000) Migrastatin, a novel 14-membered lactone from Streptomyces sp. MK929-43F. J Antibiot 53: 1228-1230. doi:10.7164/antibiotics.53.1228. PubMed: 11132973.
5. Nakamura H, Takahashi Y, Naganawa H, Nakae K, Imoto M, et al. (2002) Absolute configuration of migrastatin, a novel 14-membered ring macrolide. J Antibiot 55: 442-444. doi:10.7164/antibiotics.55.442. PubMed: 12061554.
6. Woo EJ, Starks CM, Carney JR, Arslanian R, Cadapan L, et al. (2002) Migrastatin and a new compound, isomigrastatin, from Streptomyces platensis. J Antibiot 55: 141-146. doi:10.7164/antibiotics.55.141. PubMed: 12002995.
7. Gaul C, Njardarson JT, Danishefsky SJ, (2003) The total synthesis of (+)-migrastatin. J Am Chem Soc 125: 6042-6043. doi:10.1021/ja0349103. PubMed: 12785819.
8. Njardarson JT, Gaul C, Shan D, Huang XY, Danishefsky SJ, (2004) Discovery of potent cell migration inhibitors through total synthesis: Lessons from structure-activity studies of (+)-migrastatin. J Am Chem Soc 126: 1038-1040. doi:10.1021/ja039714a. PubMed: 14746469.
9. Gaul C, Njardarson JT, Shan D, Dorn DC, Wu KD, et al. (2004) The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. J Am Chem Soc 126: 11326-11337. doi:10.1021/ja048779q. PubMed: 15355116.
10. Shan D, Chen L, Njardarson JT, Gaul C, Ma X, et al. (2005) Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc Natl Acad Sci U S A 102: 3772-3776. doi:10.1073/pnas.0500658102. PubMed: 15728385.
11. Ju J, Rajski SR, Lim SK, Seo JW, Peters NR, et al. (2008) Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency. Bioorg Med Chem Lett 18: 5951-5954. doi:10.1016/j.bmcl.2008.07.072. PubMed: 18684620.
12. Oskarsson T, Nagorny P, Krauss IJ, Perez L, Mandal M, et al. (2010) Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: In vivo and mechanistic studies on the migrastatin core ether analog. J Am Chem Soc 132: 3224-3228. doi:10.1021/ja9101503. PubMed: 20155906.
13. Lecomte N, Njardarson JT, Nagorny P, Yang G, Downey R, et al. (2011) Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin. Proc Natl Acad Sci U S A 108: 15074-15078. doi:10.1073/pnas.1015247108. PubMed: 21808037.
14. Dias LC, Finelli FG, Conegero LS, Krogh R, Andricopulo AD, (2010) Synthesis of the Macrolactone of Migrastatin and Analogues with Potent Cell-Migration Inhibitory Activity. Eur J Org Chem, 35: 6748-6759.
15. Anquetin G, Rawe SL, McMahon K, Murphy EP, Murphy PV, (2008) Synthesis of novel migrastatin and dorrigocin A analogues from D-glucal. Chem Eur J 14: 1592-1600. doi:10.1002/chem.200701033. PubMed: 18038383.
16. Anquetin G, Horgan G, Rawe S, Murray D, Madden A, et al. (2008) Synthesis of Novel Macrolactam and Macroketone Analogues of Migrastatin from D-Glucal and Comparison with Macrolactone and Acyclic Analogues: A Dorrigocin A Congener is a Potent Inhibitor of Gastric Cancer Cell Migration. Eur J Org Chem 11: 1953-1958.
17. Zhou Y, Murphy PV, (2010) Synthesis of congeners of the migrastatin and dorrigocin A core structures from D-xylose. Tetrahedron Lett 51: 5262-5264. doi:10.1016/j.tetlet.2010.07.141.
18. Chen L, Yang S, Jakoncic J, Zhang JJ, Huang XY, (2010) Migrastatin analogues target fascin to block tumor metastasis. Nature 464: 1062-1066. doi:10.1038/nature08978. PubMed: 20393565.
19. Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, (2011) Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLOS ONE 6: e27339. doi:10.1371/journal.pone.0027339. PubMed: 22076152.
20. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524. doi:10.1038/nature03799. PubMed: 16049480.
21. Król M, Polańska J, Pawłowski KM, Turowski P, Skierski J, et al. (2010) Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs. J Appl Genet 51: 37-50. doi:10.1007/BF03195709. PubMed: 20145299.
22. Queiroga FL, Raposo T, Carvalho MI, Prada J, Pires I, (2011) Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo. 25: 455-465. PubMed: 21576423.
23. Pinho SS, Carvalho S, Cabral J, Reis CA, Gärtner F, (2012) Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res 159: 165-172. doi:10.1016/j.trsl.2011.11.005. PubMed: 22340765.
24. Rowell JL, McCarthy DO, Alvarez CE, (2011) Dog models of naturally occurring cancer. Trends Mol Med 17: 380-388. doi:10.1016/j.molmed.2011.02.004. PubMed: 21439907.
25. Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, et al. (2009) Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics 10: 135. doi:10.1186/1471-2164-10-135. PubMed: 19327144.
26. Paoloni M, Khanna C, (2008) 2008) Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer. 8: 147-156. doi:10.1038/nrc2273. PubMed: 18202698.
27. Majchrzak K, Pawłowski KM, Orzechowska EJ, Dolka I, Mucha J, et al. (2012) A role of ghrelin in canine mammary carcinoma cells proliferation, apoptosis and migration. BMC. Vet Res 8: 170.
28. Rao Y, Li X, Nagorny P, Hayashida J, Danishefsky SJ, (2009) A simple method for the conversion of carboxylic acids into thioacids with Lawesson's reagent. Tetrahedron Lett 50: 6684-6686. doi:10.1016/j.tetlet.2009.09.080. PubMed: 20160926.
29. Rodriguez LG, Wu X, Guan JL, (2005) Wound-healing assay. Methods Mol Biol 294: 23-29. PubMed: 15576902.
30. Król M, Pawłowski KM, Majchrzak K, Gajwska G, Majewska A, et al. (2012) Global gene expression profiles of canine macrophages and canine mammary cancer cells grown as a co-culture in vitro. BMC. Vet Res, 8: 16.
31. Manuali E, De Giuseppe A, Feliziani F, Forti K, Casciari C, et al. (2012) CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC. Vet Res 8: 86.
32. Vignjevic D, Kojima S, Aratyn Y, Danciu O, Svitkina T, et al. (2006) Role of fascin in filopodial protrusion. J Cell Biol 174: 863-875. doi:10.1083/jcb.200603013. PubMed: 16966425.
33. Mattila PK, Lappalainen P, (2008) Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 9: 446-454. doi:10.1038/nrm2406. PubMed: 18464790.
34. Mejillano MR, Kojima S, Applewhite DA, Gertler FB, Svitkina TM, et al. (2004) Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell 118: 363-373. doi:10.1016/j.cell.2004.07.019. PubMed: 15294161.
35. Schirmer A, Kennedy J, Murli S, Reid R, Santi DV, (2006) Targeted covalent inactivation of protein kinase by resorcyclic acid lactone polyketides. Proc Natl Acad Sci U S A 103: 4234-4239. doi:10.1073/pnas.0600445103. PubMed: 16537514.